DrugPatentWatch Database Preview
Mylan Pharms Inc Company Profile
What is the competitive landscape for MYLAN PHARMS INC, and what generic alternatives to MYLAN PHARMS INC drugs are available?
MYLAN PHARMS INC has two hundred and fifty-two approved drugs.
There are eleven US patents protecting MYLAN PHARMS INC drugs. There are twenty-nine tentative approvals on MYLAN PHARMS INC drugs.
Summary for Mylan Pharms Inc
| US Patents: | 11 |
| Tradenames: | 208 |
| Ingredients: | 198 |
| NDAs: | 252 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | VALSARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; valsartan | TABLET;ORAL | 078020-001 | Sep 21, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Pharms Inc | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090970-002 | Jan 19, 2011 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Pharms Inc | TRIAZOLAM | triazolam | TABLET;ORAL | 074031-001 | Mar 25, 1994 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Pharms Inc | ERYTHROMYCIN | erythromycin | SWAB;TOPICAL | 064128-001 | Jul 3, 1996 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mylan Pharms Inc | FLUCONAZOLE | fluconazole | TABLET;ORAL | 076042-003 | Jul 29, 2004 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 4,971,800 | ➤ Sign Up |
| Mylan Pharms Inc | ZONALON | doxepin hydrochloride | CREAM;TOPICAL | 020126-001 | Apr 1, 1994 | 4,395,420 | ➤ Sign Up |
| Mylan Pharms Inc | LUXIQ | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 020934-001 | Feb 28, 1999 | 6,126,920 | ➤ Sign Up |
| Mylan Pharms Inc | DENAVIR | penciclovir | CREAM;TOPICAL | 020629-001 | Sep 24, 1996 | 5,840,763 | ➤ Sign Up |
| Mylan Pharms Inc | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for MYLAN PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Foam | 2% | ➤ Subscribe | 2009-07-30 |
| ➤ Subscribe | Topical Foam | 0.05% | ➤ Subscribe | 2005-06-27 |
| ➤ Subscribe | Foam | 0.12% | ➤ Subscribe | 2007-08-10 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Mylan Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| United Kingdom | 9001886 | ➤ Sign Up |
| Argentina | 042906 | ➤ Sign Up |
| South Korea | 0170414 | ➤ Sign Up |
| European Patent Office | 2438910 | ➤ Sign Up |
| Ireland | 910249 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Mylan Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 00086 | Netherlands | ➤ Sign Up | PRODUCT NAME: IMATINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESILAAT; NATL. REGISTRATION NO/DATE: EU/1/01/198/001 - 006 20011107; FIRST REGISTRATION: CH IKS 55807 20010621 |
| 2014000071 | Germany | ➤ Sign Up | PRODUCT NAME: KOMBINATION VON DAPAGLIFLOZIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, UND METFORMIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, GESCHUETZT DURCH DAS GRUNDPATENT EP 1 506 211; REGISTRATION NO/DATE: EU/1/13/900 20140116 |
| 2016 00016 | Denmark | ➤ Sign Up | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
| C/GB12/038 | United Kingdom | ➤ Sign Up | PRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129 |
| C0019 | France | ➤ Sign Up | PRODUCT NAME: NEVIRAPINE; NAT. REGISTRATION NO/DATE: EU/1/97/055/001 19980205; FIRST REGUSTRATION: CH/LI 54 393 19971223 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
